Author: healthprofessionalradio

Returned guest, Ken Cahill, CEO of SilverCloud Health, a digital mental health platform, discusses a new employee mental health survey of 1,288 US-based individuals that examined employees’ mental health, wellbeing, and attitudes toward employer-sponsored mental health services and digitally delivered care.  Data shows that many are struggling due to increased stress related to the COVID-19 pandemic.

Milton, a 68-year-old from Beulah, AL shares his experience of becoming 98 percent cancer free after his participation in a clinical trial for a recently FDA-approved CAR T cell therapy called BREYANZI® (lisocabtagene maraleucel) from Bristol-Myers Squibb. He was treated for a diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma.

Maya Said shares her personal story and how she came to co-found the Outcomes4Me free app to help simplify the process and improve outcomes for breast cancer patients and survivors. It connects patients to a platform that leverages AI and machine learning to analyze and consolidate medical records – regardless of provider, network, or geography – to gain access to clinical trials, approved treatments, and tools for symptom management. They have recently announced a partnership with Vanderbilt-Ingram Cancer Center to pilot a first-of-a-kind integrated survivorship platform for breast and prostate cancer patients. She talks about the uphill battle cancer patients are facing due to COVID-19 including delayed screenings and essential appointments and why now, more than ever, there needs to be a single source of truth to ensure patients are staying on top of their treatment plans.

Award-winning physician, Dr. Jill Rabin, Professor of Obstetrics and Gynecology at the Zucker School of Medicine at Hofstra Northwell discusses the recent book that she co-wrote with Gail Stein and Danielle O’Shaughnessy, called “MIND OVER BLADDER: A Step-By-Step Guide To Achieving Continence” (Morgan James, Dec 2020).  This book seeks to educate women of all ages on the many causes of incontinence and the variety of treatment options available.

Dr. Vicki Goodman, VP, Therapeutic Area Head, Late Stage Oncology at Merck discusses the recent Phase 3 KEYNOTE-204 positive EU CHMP opinion for expanded approval of KEYTRUDA® (pembrolizumab) for the treatment of relapsed or refractory classical Hodgkin lymphoma (cHL) that meet certain criteria.

Geneticist, Dr. Jennifer Ibrahim, MD, Head of North America Medical Affairs, Rare Disease at Sanofi Genzyme discusses rare genetic disease, why it’s so hard to diagnose, and the important role of genetic counselors for families who had a history of a rare genetic disease or learn of it. She talks about some new technologies and tests that are helping diagnose rare genetic diseases and what she anticipates will improve diagnosis and treatment moving forward.

Dr. Nick Medendorp, CEO of UV Innovators discusses NuvaWave, the world’s first UV handheld to demonstrate killing more than 99.9% of the live COVID virus in just one second.  He talks about the challenges of disinfection today, the value of UV light disinfection in fighting dangerous pathogens, and his mission to help businesses during these challenging times.

Ed Tracy, an award-winning broadcast veteran, writer, and editor discusses his new book “Gorilla In The Room And Other Stories” (Feb 2021) which started coming together while battling stage 3 colon cancer.

Returned guest, Bruce Boise, author of the book “Cold Comfort: One Man’s Struggle to Stop the Illegal Marketing of Powerful Opioid Drugs and Save Lives” discusses the recent 8.3 billion dollar Purdue Pharma Opioid settlement.

Allison London Brown, CEO of UVision360, Inc. in North Carolina, discusses the Luminelle DTx Hysteroscopy System. Traditionally, these procedures are conducted in a hospital or ambulatory setting. But the Luminelle system is compact and designed to be used in the doctor’s office, and the company is expected to file an application with the FDA that will allow doctors to conduct the first visual hysteroscope biopsy outside a hospital setting. This technology will help to fill an unmet medical need brought on by the COVID pandemic.